BGLAF (BioGaia AB) 3-Year EBITDA Growth Rate : 24.20% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB 3-Year EBITDA Growth Rate?

BioGaia AB's EBITDA per Share for the three months ended in Dec. 2024 was $0.11.

During the past 12 months, BioGaia AB's average EBITDA Per Share Growth Rate was 5.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 24.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of BioGaia AB was 108.40% per year. The lowest was -31.70% per year. And the median was 17.10% per year.

Competitive Comparison of BioGaia AB's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGaia AB's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where BioGaia AB's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

BioGaia AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

BioGaia AB (OTCPK:BGLAF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

BioGaia AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of BioGaia AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BGLAF) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

BIOGY:USA BIOG B:Sweden 0GTN:UK BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.